E
Elaine Kingwell
Researcher at University of British Columbia
Publications - 85
Citations - 3547
Elaine Kingwell is an academic researcher from University of British Columbia. The author has contributed to research in topics: Population & Multiple sclerosis. The author has an hindex of 28, co-authored 81 publications receiving 2924 citations. Previous affiliations of Elaine Kingwell include Nova Scotia Health Authority & Queen Elizabeth II Health Sciences Centre.
Papers
More filters
Journal ArticleDOI
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.
Elaine Kingwell,James J. Marriott,Nathalie Jette,Tamara Pringsheim,Naila Makhani,Sarah A. Morrow,John D. Fisk,John D. Fisk,Charity Evans,Sarah Gabrielle Beland,Sophie Kulaga,Jonathan Dykeman,Christina Wolfson,Marcus W. Koch,Ruth Ann Marrie +14 more
TL;DR: Despite the breadth of the literature on the epidemiology of MS in Europe, inter-study comparisons are hampered by the lack of standardization and further research should focus on regions not yet studied and the evaluation of ethnic differences in MS prevalence and incidence.
Journal ArticleDOI
Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis
Afsaneh Shirani,Yinshan Zhao,Mohammad Ehsanul Karim,Charity Evans,Elaine Kingwell,Mia L. van der Kop,Joel Oger,Paul Gustafson,John Petkau,Helen Tremlett +9 more
TL;DR: Exposure to interferon beta was not associated with a statistically significant difference in the hazard of reaching an EDSS score of 6 when either the contemporary control cohort or the historical control cohort was considered, and propensity score adjustment did not substantially change the results.
Journal ArticleDOI
The natural history of secondary progressive multiple sclerosis
TL;DR: Three factors influencing the onset of SPMS in untreated patients with RRMS in British Columbia were identified: motor onset symptoms and male gender were associated with both a shorter time to and a younger age at SPMS, while a newer age at disease onset should not be viewed as indicating a better prognosis.
Journal ArticleDOI
Incidence and Prevalence of Multiple Sclerosis in the Americas: A Systematic Review
Charity Evans,Sarah Gabrielle Beland,Sophie Kulaga,Christina Wolfson,Elaine Kingwell,James J. Marriott,Marcus W. Koch,Naila Makhani,Sarah A. Morrow,John D. Fisk,John D. Fisk,Jonathan Dykeman,Nathalie Jette,Tamara Pringsheim,Ruth Ann Marrie +14 more
TL;DR: There is a need for future studies of MS prevalence and incidence to include uniform case definitions, employ comparable methods of ascertainment, report standardized results, and be performed on a national level, as well as the inconsistencies in methodologies and quality among the published studies.
Journal ArticleDOI
The natural history of primary progressive multiple sclerosis.
TL;DR: Previous analyses in an updated PPMS retrospective cohort study of prevalent cases identified 2 predictors of a slower disease progression in primary progressive multiple sclerosis: Sensory onset symptoms were associated with both a longer time to and a higher age at Expanded Disability Status Scale (EDSS) 6.0.